Your browser doesn't support javascript.
loading
The greater impact of PNPLA3 polymorphism on liver-related events in Japanese non-alcoholic fatty liver disease patients: A multicentre cohort study.
Seko, Yuya; Yamaguchi, Kanji; Shima, Toshihide; Iwaki, Michihiro; Takahashi, Hirokazu; Kawanaka, Miwa; Tanaka, Saiyu; Mitsumoto, Yasuhide; Yoneda, Masato; Nakajima, Atsushi; Fjellström, Ola; Blau, Jenny E; Carlsson, Björn; Okanoue, Takeshi; Itoh, Yoshito.
Affiliation
  • Seko Y; Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Yamaguchi K; Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Shima T; Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Suita, Japan.
  • Iwaki M; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Takahashi H; Liver Center, Saga University Hospital, Saga, Japan.
  • Kawanaka M; General Internal Medicine 2, General Medical Center, Kawasaki Medical School, Okayama, Japan.
  • Tanaka S; Center for Digestive and Liver Diseases, Nara City Hospital, Nara, Japan.
  • Mitsumoto Y; Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Suita, Japan.
  • Yoneda M; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Nakajima A; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Fjellström O; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Blau JE; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Carlsson B; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Okanoue T; Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Suita, Japan.
  • Itoh Y; Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Liver Int ; 43(10): 2210-2219, 2023 10.
Article in En | MEDLINE | ID: mdl-37470077
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Non-alcoholic Fatty Liver Disease Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Non-alcoholic Fatty Liver Disease Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Year: 2023 Type: Article